Skip to main content
Clinical Trials/JPRN-UMIN000012831
JPRN-UMIN000012831
Recruiting
未知

To evaluate the relationships between the serum concentration of Erlotinib and the effects and toxicities of them - To evaluate the relationships between the serum concentration of Erlotinib and the effects and toxicities of them

agasaki Thoracic Oncology Group0 sites20 target enrollmentJanuary 12, 2014

Overview

Phase
未知
Intervention
Not specified
Conditions
non-squamous non-small cell lung cancer
Sponsor
agasaki Thoracic Oncology Group
Enrollment
20
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
January 12, 2014
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
agasaki Thoracic Oncology Group

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • 1\) severe cardiac effusion 2\) severe SVC syndrome 3\) severe complications 4\) severe cardiac diseases 5\) severe diabetes mellitus or hypertension 6\) severe infections 7\) Interstitial pneumonia or pulmonary fibrosis on chest CT scans 8\)history of drug allergy 9\)pregnant or or lactating women or those who declined contraception 10\)those judged not suitable by the attending physician

Outcomes

Primary Outcomes

Not specified

Similar Trials